SLRN (Acelyrin, Inc.) Kacepetan wutah bathi saben saham ing taun lumaku
Are Acelyrin, Inc. (SLRN) shares expected to rise ahead of the upcoming anti-inflammatory drug trial results? The current annual EPS growth provides the answer, where the value 21.40 reflects the actual magnitude of profit dynamics. The Acelyrin, Inc. (SLRN) business model relies on extensive outsourcing of research to third-party vendors. Consequently, the company's financial stability depends entirely on the success of clinical tests, as consistent operating revenues are currently absent.
Rincian metrik keuangan lan pasar Acelyrin, Inc. (SLRN)
- rega saham lan target rega konsensus:
- indikator valuasi pasar bisnis:
- data ekuitas miturut neraca:
- rincian utang lan likuiditas:
Rasio Total Utang marang Ekuitas Acelyrin, Inc.|SLRN - Utang jangka dawa marang modal|Kewajiban jangka cendhak marang modal acelyrin.com|SLRN - Utang perusahaan|Rasio utang marang kapitalisasi buku ACELYRIN Inc.|SLRN - Kewajiban jangka dawa perusahaan|Utang jangka cendhak ACELYRIN|Rasio jangkoan perantara acelyrin.com
- indikator pendapatan resik lan kelipatan nilai:
SLRN - Bathi resik|Prakiraan bathi perusahaan Acelyrin, Inc.|SLRN - Rasio rega marang bathi|Rasio rega marang bathi mangsa ngarep ACELYRIN Inc.|SLRN - Pangali rega marang bathi tumrap wutah|Nilai bisnis marang bathi operasional sadurunge panyusutan ACELYRIN Inc.|SLRN - Bathi operasional EBITDA|Bathi resik saben saham sajrone patang kuartal pungkasan ACELYRIN|SLRN - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan acelyrin.com|SLRN - Wutah bathi ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep Acelyrin, Inc.
Analisis dhasar perusahaan:Acelyrin Inc., SLRN
This indicator measures the year-over-year dynamics of earnings per share, allowing for an assessment of business scaling efficiency. The calculation is based on comparing current results with the previous year's data to identify the phase of the financial cycle. By analyzing the relative growth rate of earnings per share over the year, an investor can evaluate the commercial success of Acelyrin, Inc. (SLRN) in the targeted therapy segment for autoimmune pathologies.
Pesaing wigati
Haleon PLC - Tambahing bathi saben saham ing taun lumaku|KVUE (Kenvue Corp) - Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku Verona Pharma Inc. VRNA|Wutah bathi saben saham ing taun lumaku Jyong Biotech Ltd (MENS)|LGND (ligand.com) - Tambahing bathi saben saham ing taun lumaku|Wutah bathi ing taun lumaku AMRX (Amneal)|Wutah bathi ing taun lumaku Perrigo Company PLC PRGO|Alvotech Corp - Wutah bathi ing taun lumaku|Liquidia Inc. (LQDA) - Wutah bathi resik saben saham ing taun iki|GLPG: Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku anipharmaceuticals.com (ANIP)|Wutah bathi saben saham ing taun lumaku MannKind|Wutah bathi saben saham ing taun lumaku AMPH|Wutah bathi resik saben saham ing taun iki PCRX (Pacira)|SPRY - Kacepetan wutah bathi saben saham ing taun lumaku|Wutah bathi saben saham ing taun lumaku Theravance Biopharma TBPH|Tambahing bathi saben saham ing taun lumaku AQST|scPharma - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun iki Tectonic Therapeutic, Inc. TECX|Tonix Pharmaceuticals Inc. (TNXP) - Wutah bathi saben saham ing taun lumaku|Wutah bathi saben saham ing taun iki SXTC|Wutah bathi resik saben saham ing taun iki EPRX|BHST: Tambahing bathi saben saham ing taun lumaku|Wutah bathi ing taun lumaku EXOZ|Prakiraan wutah bathi resik saben saham ing taun iki oramed.com|Wutah bathi saben saham ing taun lumaku Entera Bio ENTX|HYFT: Wutah bathi saben saham ing taun iki|ABVC BioPharma - Wutah bathi ing taun lumaku|cumberlandpharma.com (CPIX) - Wutah bathi resik saben saham ing taun iki|QNTM (Quantum BioPharma) - Wutah bathi resik saben saham ing taun iki|FGEN - Prakiraan wutah bathi resik saben saham ing taun iki|Wutah bathi saben saham ing taun lumaku Telomir Pharma|Rani Therapeutics Inc (RANI) - Prakiraan wutah bathi resik saben saham ing taun iki|Wutah bathi saben saham ing taun lumaku Synergy CHC Corp (SNYR)|Wutah bathi saben saham ing taun lumaku RLYB (rallybio.com)|Wutah bathi saben saham ing taun lumaku Lexaria Bioscience Corp. LEXX|Tambahing bathi saben saham ing taun lumaku PULM|PTHL - Wutah bathi saben saham ing taun lumaku|APM (Aptorum Group Limited) - Wutah bathi saben saham ing taun iki|Lyra Therapeutics, Inc. (LYRA) - Wutah bathi saben saham ing taun lumaku|Dinamika bathi saben saham ing taun lumaku IBO (Impact BioMedical, Inc.)|TNFA (TNF Pharmaceuticals Inc.) - Wutah bathi ing taun lumaku|YCBD: Tambahing bathi saben saham ing taun lumaku|Wutah bathi ing taun lumaku PRFX|Wutah bathi ing taun lumaku altamiratherapeutics.com (CYTO)|Wutah bathi saben saham ing taun lumaku Lipella Pharmaceuticals LIPO|Tambahing bathi saben saham ing taun lumaku OPTN|PIRS - Wutah bathi saben saham ing taun lumaku|Procaps Group (PROC) - Wutah bathi resik saben saham ing taun iki|PTPI: Wutah bathi ing taun lumaku|Qilian International Corp (QLI) - Wutah bathi ing taun lumaku|Wutah bathi resik saben saham ing taun iki TFFP
